19,481 resources
By Version
By Authority
Start Prev Rows 19000 - 19200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.467 | Third Trimester_ICD10 | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.505 | Third Trimester_CPT | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.506 | Third Trimester_LOINC | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.595 | Thyroid Cancer_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.596 | Thyroid Cancer_ICD10 | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.597 | Thyroid Cancer_Grouping | active | 2025-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.274 | Total Cholesterol_CPT | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.275 | Total Cholesterol_Lab_Grouping | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.568 | Total and Partial Neph_HD_Clinical Grouping Condition_CPT | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.569 | Total and Partial Neph_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.570 | Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.572 | Kid Trans and Hx_HD_Clinical Grouping Condition_CPT | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.573 | Kid Trans and Hx_HD_Clinical Grouping Condition_HCPCS | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.574 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10CM | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.575 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.576 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9 | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.577 | Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.270 | Triglyceride_Lab_Grouping | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.523 | UTI_Clinical_Condition_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.199 | Unknown Glucose_Event_ICD9 | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.200 | Unknown Glucose_Event_ICD10 | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.201 | Unknown Glucose_Event_LOINC | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.202 | Unknown Glucose_Event_CPT | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.613 | bwell Combo Blood Pressure Vitals_UI_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.614 | bwell Combo Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.609 | bwell Systolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.610 | bwell Systolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.611 | bwell Diastolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.612 | bwell Diastolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.441 | bwell_Vital_BMI_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.431 | bwell_Vital_Blood Glucose_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.437 | bwell_Vital_Blood Oxygen_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.509 | bwell_Vital_Blood Oxygen_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.541 | bwell_Vital_Blood Pressure Panel_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.438 | bwell_Vital_Systolic Blood Pressure_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.439 | bwell_Vital_Diastolic Blood Pressure_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.511 | bwell_Vital_Diastolic Blood Pressure_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.512 | bwell_Vital_Systolic Blood Pressure_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.513 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.442 | bwell_Vital_Body Fat_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.444 | bwell_Vital_Body Height_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.445 | bwell_Vital_Body Weight_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.535 | bwell_Vital_Body Surface Area_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.536 | bwell_Vital_Body Surface Area_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.443 | bwell_Vital_Body Temperature_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.510 | bwell_Vital_Body Temperature_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.532 | bwell_Vital_Head Circumference_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.533 | bwell_Vital_Head Circumference_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.440 | bwell_Vital_Heart Rate_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.515 | bwell_Vital_Heart Rate_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.446 | bwell_Vital_Respiratory Rate_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.516 | bwell_Vital_Respiratory Rate_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.538 | bwell_Vital_Vital Signs Panel_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.539 | bwell_Vital_Vital Signs Panel_CPT | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.447 | bwell_Vital_Waist Circumference_LOINC | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.508 | bwell_Vital_Waist Circumference_SNOMED | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.5 | ADD/ADHD Condition | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping | active | 2023-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event | active | 2023-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 | active | 2023-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.253 | Asthma_Clinical Condition Grouping | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.424 | BMI >=30_Event_Clinical Condition Grouping | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.393 | BMI >=40_Event_Clinical Condition Grouping | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.453 | bwell_Vital_BMI_Clinical Grouping Event | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.448 | bwell_Vital_Blood Glucose_Clinical Grouping Lab | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.542 | bwell_Vital_Blood Pressure Panel_Clinical Grouping Event | active | 2024-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.454 | bwell_Vital_Body Fat_Clinical Grouping Event | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.456 | bwell_Vital_Body Height_Clinical Grouping Event | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event | active | 2024-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.457 | bwell_Vital_Body Weight_Clinical Grouping Event | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.514 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.558 | CABG_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.588 | COPD_Clinical Condition Grouping | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.350 | COVID19 Vaccine_Event Clinical Grouping | active | 2023-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping | active | 2023-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping | active | 2023-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition | active | 2024-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.584 | Diastolic Less than 90_HD_Clinical Grouping Event | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.567 | Essential HTN_HD_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.571 | Total and Partial Neph_HD_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.385 | Family History Hypertension (HTN)_Clinical Condition Grouping | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event | active | 2024-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.580 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event | active | 2024-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.378 | IVF_Grouping | active | 2023-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping | active | 2023-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.578 | Kid Trans and Hx_HD_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.520 | Lupus_Clinical Condition Grouping | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.553 | MI (Myocardial Infarction)_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping | active | 2023-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping | active | 2023-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.564 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event | active | 2024-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.382 | Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.504 | Prediabetes_Clinical Grouping Condition | active | 2024-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.257 | Pregnancy Loss_HD_Clinical Condition Grouping | active | 2023-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event | active | 2024-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.400 | Smoker Status_Event_Clinical Condition Grouping | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.583 | Systolic Less than 140_HD_Clinical Grouping Event | active | 2024-09 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event | active | 2024-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.524 | UTI_Clinical Condition Grouping | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.540 | bwell_Vital_Vital Signs Panel_Clinical Grouping Event | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.626 | b.well Herpes Zoster Vaccine CN_HD_Exclusions | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.627 | b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.625 | b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.622 | b.well Herpes Zoster Vaccine CN_HD_2dose | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.618 | b.well Herpes Zoster Vaccine CN_HD | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1196.1358 | Beta lactam medicinal product SNOMED | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.224 | Systolic Heart Failure I10 | active | 2025-03 | hl7 | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7106 | VPD Specimen Source Body Site | active | 2014-01 | |||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.647 | bwell Covid Vaccine CN_Allergy_SNOMED | active | 2025-04 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1196.1354 | Cefixime preparations for oral administration | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1 | ONC Administrative Sex | active | 2015-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1196.1352 | Body weight | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.58 | MMR Deficient | active | 2023-11 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.59 | MMR Deficient | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.60 | MMR Deficient | active | 2024-01 | hl7 | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.5022 | Original Specimen Source Site Modifier PHLIP | active | 2011-01 | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.5023 | Original Specimen Collection Method PHLIP | active | 2011-01 | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.11222.4.11.5025 | Original Specimen Type Modifier PHLIP | active | 2011-01 | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.5001 | Specimen Type PHLIP | active | 2011-01 | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.5024 | Original Specimen Type PHLIP | active | 2011-01 | |||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1083 | Central DXA of Hip or Spine | active | 2018-03 | hl7 | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.5016 | Organization Unit (PHLIP) | active | 2011-01 | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7794 | LikelyAte (Listeria) | active | 2018-01 | |||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1196.4467 | Urogenital & Anorectal Specimens | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.87 | Intrauterine Devices SNOMED Findings | active | 2021-10 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.199.11.1065 | Chronic Liver Disease | active | 2024-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.199.11.1067 | Chronic Liver Disease | active | 2022-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1196.4466 | Pharyngeal specimens | active | 2024-05 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1097 | Marfan's Syndrome | active | 2022-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.117.12.1009 | Cushings Syndrome | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1085 | Osteogenesis Imperfecta | active | 2022-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1087 | Osteogenesis Imperfecta | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1088 | Ankylosing Spondylitis | active | 2021-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1090 | Ankylosing Spondylitis | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1091 | Psoriatic Arthritis | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1093 | Psoriatic Arthritis | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1096 | Ehlers Danlos Syndrome | active | 2022-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1099 | Marfan's Syndrome | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1100 | Osteopenia | active | 2018-08 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.11.1102 | Osteopenia | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.12.1044 | Osteogenesis Imperfecta | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.12.1045 | Ankylosing Spondylitis | active | 2023-12 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.12.1046 | Psoriatic Arthritis | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.12.1048 | Marfan's Syndrome | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.113.12.1049 | Osteopenia | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.117.11.1023 | Cushings Syndrome | active | 2021-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.117.11.1025 | Cushings Syndrome | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.117.11.1026 | Lupus | active | 2023-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.117.11.1028 | Lupus | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.117.12.1010 | Lupus | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.199.11.1068 | Chronic Malnutrition | active | 2023-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.199.11.1070 | Chronic Malnutrition | active | 2018-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.199.12.1036 | Chronic Malnutrition | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1021.120 | Patient Sex for Quality Measurement | active | 2024-10 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.464.1003.199.12.1035 | Chronic Liver Disease | active | 2024-01 | hl7 | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3289 | Vaccination Reaction and Adverse Event (IIS) | active | 2012-01 | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.4028 | Lab Result (Ebolavirus) | active | 2015-01 |